Do recent operational studies indicate that a single state model is no longer applicable to G protein-coupled receptors?

Annals of the New York Academy of Sciences

Volumn 812, Issue , 1997, Pages 92-97

  Bond, Richard A ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

GENETIC TRANSFECTION; MODEL; MOUSE; NONHUMAN; REVIEW; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0030752539     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48149.x     Document Type: Review

References (24)

1. KENAKIN, T. P. 1988. Are receptors promiscuous? Intrinsic efficacy as a transduction phenomenon. Life Sci. 43: 1095-1101.
2. LEFF, P. & D. HARPER. 1989. Do pharmacological methods for the quantification of agonists work when the ternary complex mechanism operates? J. Theor. Biol. 140: 381-397.
3. MACKAY, D. 1988. Continuous variation of agonist affinity constants. Trends Pharmacol. Sci. 9: 156-157.
4. MILLIGAN, G., R. A. BOND & M. LEE. 1995. Inverse agonism: Pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol. Sci. 16: 10-13.
5. COSTA, T. & A. HERZ. 1989. Antagonists with negative intrinsic activity at d opioid receptors coupled to GTP-binding proteins. Proc. Natl. Acad. Sci. USA 86: 7321-7325.
6. COSTA, T., J. LANG, C. GLESS & A. HERZ. 1990. Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: Specific regulation by antagonists and sodium ions. Mol. Pharmacol. 37: 383-394.
7. DELEAN, A., J. M. STADEL & R. J. LEFKOWITZ. 1980. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255: 7108-7117.
8. 2-adrenergic receptor activation of G proteins: Evidence for a precoupled receptor/G protein state. Mol. Pharmacol. 45: 524-531.
9. 2-adrenergic receptor. J. Biol. Chem. 268: 4625-4636.
10. 2-adrenergic receptor. Mol. Pharmacol. 45: 390-394.
11. LEFKOWITZ, R. J., S. COTECCHIA, P. SAMAMA & T. COSTA. 1993. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14: 303-307.
12. CHIDIAC, P., T. E. HEBERG, M. VALIQUETTE, M. DENNIS & M. BOUVIER. 1994. Inverse agonist activity of β-adrenergic antagonists. Mol. Pharmacol. 45: 490-499.
13. TIBERL, M. & M. G. CARON. 1994. High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J. Biol. Chem. 269: 27925-27931.
14. 2C receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 269: 11687-11690.
15. LABRECQUE, J., A. FARGIN, M. BOUVIER, P. CHIDIAC & M. DENNIS. 1995. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells. Mol. Pharmacol. 48: 150-159.
16. GOTZE, K. & K. H. JAKOBS. 1994. Unoccupied β-adrenoceptor-induced adenylyl cyclase stimulation in turkey erythrocyte membranes. Eur. J. Pharmacol. 268: 151-158.
17. MEWES, T., S. DUTZ, U. RAVENS & K. H. JAKOBS. 1993. Activation of calcium currents in cardiac myocyte by empty β-adrenergic receptors. Circulation 88: 2916-2922.
18. HANF, R., Y. LI, G. SZABO & R. FISCHMEISTER. 1993. Agonist-independent effects of muscarinic antagonists on Ca2+ and K+ currents in frog and rat cardiac cells. J. Physiol. (Lond.) 461: 743-765.
19. 2-adrenergic receptor. Science 264: 582-586.
20. GURDAL, H. & M. JOHNSON. 1995. Personal communication.
21. 2-adrenoceptor. Nature 374: 272-276.
22. CLARK, A. J. 1933. The Mode of Action of Drugs on Cells. London.
23. KENAKIN, T. P. 1989. Challenges for receptor theory as a tool for drug and drug receptor interactions. Trends Pharmacol. Sci. 10: 18-22.
24. 2-adrenoceptor. Mol. Pharmacol. 48: 316-325.